Wall Street Zen downgraded shares of Amdocs (NASDAQ:DOX – Free Report) from a buy rating to a hold rating in a research report released on Saturday morning.
Other equities analysts have also issued reports about the stock. Barclays dropped their price objective on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 4th. Stifel Nicolaus reduced their target price on shares of Amdocs from $97.00 to $88.00 and set a “buy” rating for the company in a report on Wednesday, February 4th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Amdocs in a report on Tuesday, January 27th. Three investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, Amdocs presently has a consensus rating of “Moderate Buy” and a consensus price target of $92.33.
Read Our Latest Stock Report on Amdocs
Amdocs Stock Performance
Amdocs (NASDAQ:DOX – Get Free Report) last posted its quarterly earnings results on Tuesday, February 3rd. The technology company reported $1.81 earnings per share for the quarter, beating analysts’ consensus estimates of $1.75 by $0.06. Amdocs had a return on equity of 20.19% and a net margin of 12.47%.The business had revenue of $1.16 billion for the quarter, compared to analysts’ expectations of $1.15 billion. During the same quarter in the prior year, the business earned $1.66 EPS. The firm’s revenue for the quarter was up 4.1% on a year-over-year basis. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. As a group, equities research analysts predict that Amdocs will post 6.21 EPS for the current year.
Amdocs Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Tuesday, March 31st will be given a dividend of $0.569 per share. This represents a $2.28 annualized dividend and a yield of 3.5%. The ex-dividend date is Tuesday, March 31st. This is a positive change from Amdocs’s previous quarterly dividend of $0.53. Amdocs’s dividend payout ratio (DPR) is 40.81%.
Institutional Investors Weigh In On Amdocs
A number of institutional investors have recently modified their holdings of the business. Harbor Capital Advisors Inc. bought a new position in Amdocs during the third quarter worth about $26,000. Root Financial Partners LLC bought a new stake in Amdocs in the 3rd quarter valued at about $26,000. WealthCollab LLC grew its position in shares of Amdocs by 94.5% during the 3rd quarter. WealthCollab LLC now owns 356 shares of the technology company’s stock worth $29,000 after purchasing an additional 173 shares in the last quarter. Atlantic Union Bankshares Corp acquired a new position in shares of Amdocs during the 3rd quarter worth approximately $37,000. Finally, BOK Financial Private Wealth Inc. bought a new position in shares of Amdocs during the fourth quarter worth approximately $37,000. Institutional investors own 92.02% of the company’s stock.
About Amdocs
Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.
Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.
Featured Articles
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
